v3.26.1
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Cash flows from operating activities:    
Net (loss) income $ (5,593) $ 1,284
Adjustments to reconcile net (loss) income to net cash provided by operating activities:    
Depreciation, amortization, and accretion 5,613 5,942
Stock-based compensation 2,055 1,751
Allowance for accounts receivable 337 0
Loss from investments in other entities 1,757 722
Distributions from return on investments in other entities 414 956
Deferred income taxes (5,709) 0
Other (448) 1,240
Changes in operating assets and liabilities:    
Accounts receivable [1] 18,918 8,689
Parts inventory (1,237) (2,566)
Prepaid expenses and other current and long-term assets 8,799 10,810
Accounts payable [2] (9,088) 4,621
Accrued expenses and other current and non-current liabilities (2,902) (3,770)
Net cash provided by operating activities 12,916 29,679
Cash flows from investing activities:    
Purchase of property, plant, and equipment (24,367) (11,566)
Distributions from return of investments in other entities 5,961 7,939
Cash paid, related to investments in other entities (978) (5,650)
Net cash used in investing activities (19,384) (9,277)
Cash flows from financing activities:    
Proceeds from loans 128,382 0
Repayment of loans (33,058) (423)
Proceeds from redeemable preferred non-controlling interest and warrants issuance, net of issuance costs 116,670 0
Redemption of redeemable preferred non‑controlling interest (100,000) 0
Financing costs paid to other third parties (435) (1,250)
Repayment of principal portion of finance lease liabilities (328) 0
Payment of preferred dividends (3,444) (2,617)
Distribution to non-redeemable non-controlling interest (65) (60)
Cash paid for taxes related to net share settlement of equity awards 0 (382)
Capital contribution from non-redeemable non-controlling interests 7,402 0
Net cash provided by (used in) financing activities 115,124 (4,732)
Net increase in cash, restricted cash, and cash equivalents 108,656 15,670
Cash, restricted cash, and cash equivalents, beginning of period 28,318 29,228
Cash, restricted cash, and cash equivalents, end of period 136,974 44,898
Supplemental disclosure of cash flow information    
Interest paid, net of $398 and $524 capitalized, respectively 6,749 6,625
Noncash investing and financing activities:    
Issuance of warrants in connection with redeemable preferred non-controlling interest financing 2,760 0
Purchase of property, plant and equipment included in accrued expenses and other current liabilities $ 24,632 $ 26,808
[1] Includes (increase) decrease from related parties of $(2,009) and $7,461 for the three months ended March 31, 2026 and 2025, respectively
[2] Includes decrease from related parties of $(6,055) and $(2,299) for the three months ended March 31, 2026 and 2025, respectively